Positive urinary antigen tests for Streptococcus pneumoniae in community-acquired pneumonia: A 7-year retrospective evaluation of health care cost and treatment consequences

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 32, Issue 4, 2013, Pages 485-492

  Engel, M F ^a   Van Velzen, M ^a   Hoepelman, A I M ^a   Thijsen, S ^b   Oosterheert, J J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b DEPARTMENT OF SURGERY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; ERYTHROMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL DECISION MAKING; CLINICAL PROTOCOL; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONFUSION UREA RESPIRATORY RATE BLOOD PRESSURE AGE 65 SCORE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; ECONOMIC EVALUATION; FEMALE; HEALTH CARE COST; HUMAN; INTENSIVE CARE; LABORATORY DIAGNOSIS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MONOTHERAPY; NONHUMAN; PNEUMONIA SEVERITY INDEX SCORE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY ANALYSIS; STREPTOCOCCUS PNEUMONIAE; TEACHING HOSPITAL; TREATMENT DURATION; TREATMENT OUTCOME; URINARY ANTIGEN TEST;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; CLINICAL LABORATORY TECHNIQUES; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HEALTH CARE COSTS; HOSPITALS, TEACHING; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; RETROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE;

EID: 84879461667     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1761-0     Document Type: Article

References (20)

1. Wiersinga WJ, Bonten MJ, Boersma WG, Jonkers RE, Aleva RM, Kullberg BJ et al (2012) SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adults. Neth J Med 70(2):90-101
2. Dutch Infectious Diseases Surveillance Information System for Antimicrobial Resistance (ISIS-AR). Available online at: https://www.isis-web. nl/interactieve-rapporten/bezoekvraag/
3. Garau J (2005) Role of beta-lactam agents in the treatment of community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 24(2):83-99 (Pubitemid 40487376)
4. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I et al (2009) BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 64(Suppl 3):iii1-iii55
5. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC et al (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27-S72 (Pubitemid 46290553)
6. Schouten JA, Prins JM, Bonten MJ, Degener J, Janknegt RE, Hollander JM et al (2005) Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia. Neth J Med 63(8):323-335
7. American Thoracic Society; Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171(4):388-416 (Pubitemid 40227463)
8. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI et al (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58(5):377-382 (Pubitemid 36560938)
9. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE et al (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336(4):243-250 (Pubitemid 27044625)
10. Tariff application of urinary antigen test, declaration code 071137. Available online at: http://dbc-tarieven.nza.nl/Nzatarieven/
11. Medication costs. Available online at: http://www.medicijnkosten.nl
12. Oosterheert JJ, Bonten MJ, Buskens E, Schneider MM, Hoepelman IM (2003) Algorithm to determine cost savings of targeting antimicrobial therapy based on results of rapid diagnostic testing. J Clin Microbiol 41(10):4708-4713 (Pubitemid 37259782)
13. Matta M, Kernéis S, Day N, Lescat M, Hoi AB, Varon E et al (2010) Do clinicians consider the results of the BinaxNOW Streptococcus pneumoniae urinary antigen test when adapting antibiotic regimens for pneumonia patients? Clin Microbiol Infect 16(9):1389-1393
14. Kobashi Y, Yoshida K, Miyashita N, Niki Y, Matsushima T (2007) Evaluating the use of a Streptococcus pneumoniae urinary antigen detection kit for the management of community-acquired pneumonia in Japan. Respiration 74(4):387-393 (Pubitemid 47093150)
15. Korsgaard J, Møller JK, Kilian M (2005) Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract infections in adults. Int J Infect Dis 9(5):274-279 (Pubitemid 41196871)
16. Weatherall C, Paoloni R, Gottlieb T (2008) Point-of-care urinary pneumococcal antigen test in the emergency department for community acquired pneumonia. Emerg Med J 25(3):144-148 (Pubitemid 351351105)
17. Falguera M, Ruiz-González A, Schoenenberger JA, Touzón C, Gázquez I, Galindo C et al (2010) Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia. Thorax 65(2):101-106
18. Oostdijk EA, de Smet AM, Kesecioglu J, Bonten MJ; Dutch SOD-SDD Trialists Group (2011) The role of intestinal colonization with gram-negative bacteria as a source for intensive care unit-acquired bacteremia. Crit Care Med 39(5):961-966
19. de Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS et al (2009) Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 360(1):20-31
20. Hak E, Grobbee DE, Sanders EA, Verheij TJ, Bolkenbaas M, Huijts SM et al (2008) Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults. Neth J Med 66(9):378-383